Pfizer and BioNTech's Covid-19 vaccine could be rolled out in Europe this month, the companies said after they applied for EU emergency approval.
The application to the European Medicines Agency (EMA) comes days after the companies applied for emergency use of their vaccine in the United States.
They said their candidate, BNT162b2, could be launched in the European Union this month. "If EMA concludes that the benefits of the vaccine candidate outweigh its risks in protecting against Covid-19, it will recommend granting a CMA (conditional marketing authorisation) that could potentially enable use of BNT162b2 in Europe before the end of 2020," they said in a joint statement.